Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides October 29, 2019
Ceapro to Present PGX Technology at the 3rd International Symposium on Pharmaceutical Engineering Research September 25, 2019
Ceapro Inc. Reports 2019 Second Quarter and Six-Month Financial Results and Operational Highlights August 28, 2019
Ceapro Announces Research Funding Award from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada for Joint Projects with McMaster University August 27, 2019
Ceapro Inc. Announces Signing of a Contribution Agreement with National Research Council of Canada August 15, 2019
Ceapro Presents Positive Results from Avenanthramides Study at the 2019 American Society of Sports Medicine Meeting June 5, 2019